Catechol-O-methyltransferase inhibitors in Parkinsons disease
This review focuses on the history of serotonin, the state of current central serotonin research, previous serotonergic therapies, and the future of serotonin for treating individuals with obesity
Am J Physiol Cel Physiol 2021;321:C770-C778
Ronald Petersen, a neurologist at the Mayo Clinic in Rochester, Minnesota, who was not involved in the research, said a possible explanation for the disappointing results could be flaws in the trials, including that researchers gave participants too low a dose
It works best with diet and exercise, as your lifestyle could directly impact the results
In such a case, we recommend peptides under the eyes The effects of their use are visible almost immediately